These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32597012)

  • 41. Biomarkers for the diagnosis and management of Parkinson's disease.
    Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
    Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autonomic disorders predicting Parkinson's disease.
    Palma JA; Kaufmann H
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S94-8. PubMed ID: 24262198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The search for biomarkers in Parkinson's disease: a critical review.
    Antoniades CA; Barker RA
    Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.
    Lang AE
    Mov Disord; 2011 Apr; 26(5):775-83. PubMed ID: 21484865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarkers of Parkinson's Disease: An Introduction.
    Titova N; Qamar MA; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease.
    O'Keeffe GW; Sullivan AM
    Parkinsonism Relat Disord; 2018 Nov; 56():9-15. PubMed ID: 29934196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prodromal PD: A new nosological entity.
    Schaeffer E; Postuma RB; Berg D
    Prog Brain Res; 2020; 252():331-356. PubMed ID: 32247370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there a need to redefine Parkinson's disease?
    Mahlknecht P; Poewe W
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S9-17. PubMed ID: 23715973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.
    Zou J; Weng RH; Chen ZY; Wei XB; Wang R; Chen D; Xia Y; Wang Q
    CNS Neurosci Ther; 2016 Mar; 22(3):167-77. PubMed ID: 26776081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers of Nonmotor Symptoms in Parkinson's Disease.
    Konno T; Al-Shaikh RH; Deutschländer AB; Uitti RJ
    Int Rev Neurobiol; 2017; 133():259-289. PubMed ID: 28802922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
    Miraglia F; Betti L; Palego L; Giannaccini G
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.
    Siderowf A; Stern MB
    Ann Neurol; 2008 Dec; 64 Suppl 2():S139-47. PubMed ID: 19127581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis.
    Bhat S; Acharya UR; Hagiwara Y; Dadmehr N; Adeli H
    Comput Biol Med; 2018 Nov; 102():234-241. PubMed ID: 30253869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study.
    Maremmani C; Cavallo F; Purcaro C; Rossi G; Salvadori S; Rovini E; Esposito D; Pieroni A; Ramat S; Vanni P; Fattori B; Meco G
    Acta Neurol Scand; 2018 Feb; 137(2):204-211. PubMed ID: 29082509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
    Postuma RB; Aarsland D; Barone P; Burn DJ; Hawkes CH; Oertel W; Ziemssen T
    Mov Disord; 2012 Apr; 27(5):617-26. PubMed ID: 22508280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prodromes of Parkinson's disease.
    Rees RN; Noyce AJ; Schrag A
    Eur J Neurosci; 2019 Feb; 49(3):320-327. PubMed ID: 30447019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of Parkinson's Disease: From Risk Factors to Early Interventions.
    Ng MG; Chan BJL; Koh RY; Ng KY; Chye SM
    CNS Neurol Disord Drug Targets; 2024; 23(6):746-760. PubMed ID: 37326115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging targets for the diagnosis of Parkinson's disease: examination of systemic biomarkers.
    Cheslow L; Snook AE; Waldman SA
    Biomark Med; 2021 Jun; 15(8):597-608. PubMed ID: 33988462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.